Mr. Rydzewski is a private investor who serves as advisor and director to healthcare companies and health policy and education organizations. As an investment banker at Solomon Partners, Benedetto, Gartland & Co., Kidder Peabody, Inc. and Dean Witter Reynolds Inc, he provided advisory and capital raising services for healthcare and life science companies in the biotech and drug development services sectors; hospital management and long-term care, including assisted living and skilled nursing care; behavioral health and managed care.In addition to investment banking, he founded a pre-clinical stage biotech company developing cancer-targeting immuno-therapeutics with technology licensed from the Massachusetts Institute of Technology and Harvard University. He was a Managing Director focused on structured credit investments in the pharmaceutical sector at Christofferson Robb & Company, a private investment firm. He was the senior manager in the bankruptcy and insolvency group, performing both creditor committee and debtor assignments, at Price Waterhouse & Co.